Abstract
Inactivation by hydrogen peroxide and pH manipulation are two novel methods used recently in experimental vaccines against Streptococcus agalactiae in Nile tilapia. Here we describe in detail inactivation using novel methods as well as the classical method of inactivation. These vaccines showed similar moderate efficacy when compared to the conventional formaldehyde vaccine. In addition, we describe the inclusion of adjuvants in a hydrogen peroxide vaccine.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ye X, Li J, Lu M, Deng G, Jiang X, Tian Y, Quan Y, Jian Q (2011) Identification and molecular typing of Streptococcus agalactiae isolated from pond-cultured tilapia in China. Fish Sci 77:623–632. https://doi.org/10.1007/s12562-011-0365-4
Lusiastuti A, Textor M, Seeger H, Akineden O, Zschock M (2014) The occurrence of Streptococcus agalactiae sequence type 261 from fish disease outbreaks of tilapia Oreochromis niloticus in Indonesia. Aquac Res 45:1260–1263. https://doi.org/10.1111/are.12069
Mishra A, Nam GH, Gim JA, Lee HE, Jo A, Kim HS (2018) Current challenges of streptococcus infection and effective molecular, cellular, and environmental control methods in aquaculture. Mol Cells 41:495–505. https://doi.org/10.14348/molcells.2018.2154
Barony GM, Tavares GC, Pereira FL, Carvalho AF, Dorella FA, Leal CA et al (2017) Large-scale genomic analyses reveal the population structure and evolutionary trends of Streptococcus agalactiae strains in Brazilian fish farms. Sci Rep 7(1):13538. https://doi.org/10.1038/s41598-017-13228-z
Liu G, Zhu J, Chen K, Gao T, Yao H, Liu Y et al (2016) Development of Streptococcus agalactiae vaccines for tilapia. Dis Aquat Org 122(2):163–170. https://doi.org/10.3354/dao03084
Munang’andu HM, Mutoloki S, Evensen Ø (2014) Non-replicating vaccines. In: Gudding R, Lillehaug A, Evensen Ø (eds) Fish vaccination. Wiley Blackwell, UK
Pasnik DJ, Evans JJ, Panangala VS, Klesius PH, Shelby RA, Shoemaker CA (2005) Antigenicity of Streptococcus agalactiae extracellular products and vaccine efficacy. J Fish Dis 28:205–212. https://doi.org/10.1111/j.1365-2761.2005.00619.x
Pretto-giordano LG, Muller EE, Klesius P, Silva VG (2010) Efficacy of an experimentally inactivated Streptococcus agalactiae vaccine in Nile tilapia (Oreochromis niloticus) reared in Brazil. Aqua Res 41:1539–1544. https://doi.org/10.1111/j.1365-2109.2009.02449.x
Chen M, Wang R, Li L, Liang W, Li J, Huang Y, Lei A, Huang W, Gan X (2012) Screening vaccine candidate strains against Streptococcus agalactiae of tilapia based on PFGE genotype. Vaccine 30:6088–6092. https://doi.org/10.1016/j.vaccine.2012.07.044
Tu FP, Chu WH, Zhuang XY, Lu CP (2010) Effect of oral immunization with Aeromonas hydrophila ghosts on protection against experimental fish infection. Lett Appl Microbiol 50:13–17. https://doi.org/10.1111/j.1472-765X.2009.02746.x
Amanna IJ, Raué H, Slifka MK (2012) Development of a new hydrogen-peroxide-based vaccine platform. Nat Med 18:974–980. https://doi.org/10.1038/nm.2763
Fan Y, Mu Y, Lu L, Tian Y, Yuan F, Zhou B, Yu C, Wang Z, Li X, Lei S, Xu Y, Wu D, Yang L (2019) Hydrogen peroxide-inactivated bacteria induces potent humoral and cellular immune responses and releases nucleic acids. Int Immunopharmacol 69:389–307. https://doi.org/10.1016/j.intimp.2019.01.055
Pinto AK, Richner JM, Poore EA, Patil PP, Amanna IJ, Slifka MK et al (2013) A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice. J Virol 87(4):1926–1936. https://doi.org/10.1128/JVI.02903-12
Poore EA, Slifka DK, Raué HP, Thomas A, Hammarlund E, Quintel BK et al (2017) Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine. Vaccine 35(2):283–292. https://doi.org/10.1016/j.vaccine.2016.11.080
Nguyen TD, Crosbie PBB, Nowak BF, Bridle AR (2018) The effects of inactivation methods of Yersinia ruckeri on the efficacy of single dip vaccination in Atlantic salmon (Salmo salar). J Fish Dis 41:1173–1176. https://doi.org/10.1111/jfd.1280
Ramos-Espinoza FC, Cueva-Quiroz VC, Yunis-Aguinaga J, Moraes JRE (2020) A comparison of novel inactivation methods for production of a vaccine against Streptococcus agalactiae in Nile tilapia Oreochromis niloticus. Aquaculture 528:735484. https://doi.org/10.1016/j.aquaculture.2020.735484
Ramos-Espinoza FC, Cueva-Quiroz VC, Yunis-Aguinaga J, Alvarez-Rubio NC, Mello NP, JRE M (2020) Efficacy of two adjuvants administrated with a novel hydrogen peroxide-inactivated vaccine against Streptococcus agalactiae in Nile tilapia fingerlings. Fish Shellfish Immunol 105:350–358. https://doi.org/10.1016/j.fsi.2020.07.051
Marcusso PF, Eto SF, Claudiano GS, Vieira FCF, Salvador R, Moraes JRE et al (2015) Isolamento de Streptococcus agalactiae em diferentes órgãos de tilápias do nilo (Oreochromis niloticus) criadas em tanques-rede. Biosci J 31(2):549–554. https://doi.org/10.14393/BJ-v31n2a2015-22504
Salvador R, Muller E, Freitas J, Leonhadt J, Pretto-giordano L, Dias J (2005) Isolamento e caracterização de Streptococcus spp. do grupo B em tilápias do Nilo (Oreochromis niloticus) criadas em tanques rede e em viveiros de terra na região norte do Estado do Paraná, Brasil. Cienc Rural 35:1374–1378. https://doi.org/10.1590/S0103-84782005000600023
Delannoy C, Crumlish M, Fontaine M, Pollock J, Foster G, Dagleish M, Turnbull J, Zadoks R (2013) Human Streptococcus agalactiae strains in aquatic mammals and fish. BMC Microbiol 13:1–9. https://doi.org/10.1186/1471-2180-13-41
Amend DF (1981) Potency testing of fish vaccines. Fish Biol 49:447–454
Acknowledgments
This work was supported by the São Paulo Research Foundation (Fapesp)—Grant 2018/06137-1 and 2019/02339-1 and Scholarship 2016/18345-2, and the National Council for Scientific and Technological Development (CNPq)—Scholarship 141835/2018-4. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES) - Finance Code 001.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ramos-Espinoza, F.C., Cueva-Quiroz, V.A., Yunis-Aguinaga, J., Alvarez-Rubio, N.C., de Mello, N.P., de Moraes, J.R.E. (2022). Testing Novel Inactivation Methods and Adjuvants for Vaccines Against Streptococcus agalactiae in Nile Tilapia Oreochromis niloticus. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 2411. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1888-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1888-2_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1887-5
Online ISBN: 978-1-0716-1888-2
eBook Packages: Springer Protocols